Related Experiment Videos
Intraocular and extraocular retinoblastoma
1Division of Pediatric Hematology/Oncology, New York Hospital, New York.
Hematology/Oncology Clinics of North America
|December 1, 1987
Summary
Pediatricians and oncologists can now significantly improve retinoblastoma (eye cancer) treatment and genetic counseling. Advances enable better survival rates and necessitate lifelong monitoring for secondary cancers in affected children.
Area of Science:
- Pediatric Oncology
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Retinoblastoma is the most common childhood eye cancer.
- Pediatricians and oncologists have an increasing role in managing this disease.
- Genetic factors play a crucial role in retinoblastoma development.
Purpose of the Study:
- To highlight advancements in retinoblastoma diagnosis and treatment.
- To emphasize the importance of genetic counseling for families.
- To present a staging system and therapeutic strategies for extraocular retinoblastoma.
Main Methods:
- Utilizing molecular biology for carrier testing and prenatal diagnosis.
- Implementing a practical staging system for extraocular retinoblastoma.
- Applying stage-related chemotherapy and radiation therapy.
Main Results:
- Improved genetic counseling capabilities for affected families.
- Increased long-term survival rates for the majority of patients with metastatic retinoblastoma.
- Identification of a lifelong risk for secondary nonocular malignancies in 40% of patients.
Conclusions:
- Advances in molecular biology and treatment modalities have significantly improved outcomes for retinoblastoma.
- Vigilant long-term follow-up is essential for patients with germinal mutations due to the risk of secondary cancers.